Severe pneumonia due to infection with Candida krusei in a case of suspected Middle East respiratory syndrome: A case report and literature review

Tan,Mingming; Wang,Junwei; Hu,Peiyang; Wang,Bin; Xu,Wanghua; Chen,Jiao

doi:10.3892/etm.2016.3892

Severe pneumonia due to infection with Candida krusei in a case of suspected Middle East respiratory syndrome: A case report and literature review

Authors:
- Mingming Tan
- Junwei Wang
- Peiyang Hu
- Bin Wang
- Wanghua Xu
- Jiao Chen
View Affiliations

Affiliations: Emergency Department, Tiantai County People's Hospital, Taizhou, Zhejiang 317200, P.R. China
Published online on: November 11, 2016 https://doi.org/10.3892/etm.2016.3892
Pages: 4085-4088

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Candida krusei (C. krusei) pneumonia is a rare infection that is frequently associated with a poor outcome. The present study reports an unusual case of C. krusei pneumonia that was initially suspected to be a Middle East respiratory syndrome (MERS) case. A 64‑year‑old Saudi Arabian male patient was admitted to our hospital with complaints of cough and dyspnea that persisted for 6 days. The patient presented fever (oral temperature, 38.5˚C) and slight tachypnea (25 respirations/min). A chest computerized tomography demonstrated unclear lung fields, diffuse pathological changes in the two lungs and multiple lymphadenectasis in the retrocaval and para‑aortic arch area. The patient received 95‑98% oxygen (6 l/min) for 24 h, as well as sulbactam sodium/cefoperazone sodium (1:1) injection (3.0 g) every 12 h, oral oseltamivir capsules (75 mg/time) twice a day, medaron injection (80 mg/time) and 750 ml fluid infusion; however, he succumbed to the disease on day 2 after admission. The infection was diagnosed by sputum smear and culture subsequent to patient mortality. A sputum smear showed a large fungal infection and sputum culture revealed the presence of C. krusei infection. Serum procalcitonin concentrations were 4.73 µg/l and 7.23 µg/l on days 2 and 3 after admission, respectively. In conclusion, the diagnosis of Candida pneumonia should be strongly considered in the presence of growth of Candida from a sputum culture and based on a suggestive computed tomography image. Tumescent diaphragmatic lymph nodes may also be an important symptom of Candida pneumonia. Treatment should be initiated immediately to improve tissue oxygenation, restore cardiovascular function and improve other organ functions.

View Figures

View References

1	Haron E, Vartivarian S, Anaissie E, Dekmezian R and Bodey GP: Primary Candida pneumonia: Experience at a large cancer center and review of the literature. Medicine (Baltimore). 72:137–142. 1993. View Article : Google Scholar : PubMed/NCBI
2	Von Eiff M, Roos N, Fegeler W, Von Eiff C, Schulten R, Hesse M, Zühlsdorf M and Van de Loo J: Hospital - acquired candida and aspergillus pneumonia - diagnostic approaches and clinical findings. J Hosp Infect. 32:17–28. 1996. View Article : Google Scholar : PubMed/NCBI
3	Petrocheilou-Paschou V, Georgilis K, Kontoyannis D, Nanas J, Prifti H, Costopoulos H and Stamatelopoulos S: Pneumonia due to Candida krusei. Clin Microbiol Infect. 8:806–809. 2002. View Article : Google Scholar : PubMed/NCBI
4	Carvajal C, Rello J and Lipman J: Candida pneumonia in patients with hematological neoplasiaPulmonary Involvement in Patients with Hematological Malignancies. Azoulay E: Springer; Berlin: pp. 349–356. 2011, View Article : Google Scholar
5	Masur H, Rosen PP and Armstrong D: Pulmonary disease caused by Candida species. Am J Med. 63:914–925. 1977. View Article : Google Scholar : PubMed/NCBI
6	von Rosenstein NR: The diseases of children and their remedies. The Classics of Medicine Library, Wenneberg and Nordstrom; Stockholm: 1984
7	Castellani A: Notes on certain bronchomycoses which may simulate pulmonary tuberculosis. Am Rev Tuberc. 16:1927–1928. 1927.
8	Mohsenifar Z, Chopra SK, Johnson BL and Simmons DH: Candida pneumonia: Experience with 20 patients. West J Med. 131:196–200. 1979.PubMed/NCBI
9	Schröter GP, Hoelscher M, Putnam CW, Porter KA and Starzl TE: Fungus infections after liver transplantation. Ann Surg. 186:115–122. 1977. View Article : Google Scholar : PubMed/NCBI
10	Buff SJ, McLelland R, Gallis HA, Matthay R and Putman CE: Candida albicans pneumonia: radiographic appearance. Am J Roentgenol. 138:645–648. 1982. View Article : Google Scholar
11	Imtiaz T, Thomson F, Innes A, du Toit FC and Bal AM: Candida krusei bronchopneumonia with nodular infiltrates in a patient with chronic renal failure on haemodialysis - case report and review of literature. Mycoses. 54:e611–e614. 2011. View Article : Google Scholar : PubMed/NCBI
12	Meersseman W, Lagrou K, Spriet I, Maertens J, Verbeken E, Peetermans W and Van Wijngaerden E: Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intens Care Med. 35:1526–1531. 2009. View Article : Google Scholar
13	Gogia P: Pulmonary fungal infections. Current Medicine Research and Practice. 5:221–227. 2015. View Article : Google Scholar
14	Kontoyiannis D, Reddy B, Torres H, Luna M, Lewis R, Tarrand J, Bodey G and Raad I: Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis. 34:400–403. 2002. View Article : Google Scholar : PubMed/NCBI
15	Rodriguez L, Anaissie E and Rex J: Pneumonia due to Candida speciesSarosi GA and Davies SF: Fungal disease of the lung. 3rd. Lippincott Williams & Wilkins; Philadelphia: pp. 115–122. 2000
16	Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD and Fouchier RA: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 367:1814–1820. 2012. View Article : Google Scholar : PubMed/NCBI
17	Galván B and Mariscal F: Epidemiology of candidemia in ICU. Rev Iberoam Micol. 23:12–15. 2006.(In Spanish). View Article : Google Scholar : PubMed/NCBI
18	Fidan I, Yesilyurt E, Kalkanci A, Aslan SO, Sahin N, Ogan MC and Dizbay M: Immunomodulatory effects of voriconazole and caspofungin on human peripheral blood mononuclear cells stimulated by Candida albicans and Candida krusei. Am J Med Sci. 348:219–223. 2014. View Article : Google Scholar : PubMed/NCBI
19	WHO MERS-CoV Research Group, . State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr. 5:2013.
20	Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, et al: Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study. Lancet Infect Dis. 13:752–761. 2013. View Article : Google Scholar : PubMed/NCBI
21	Vélez L, Correa LT, Maya MA, Mejía P, Ortega J, Bedoya V and Ortega H: Diagnostic accuracy of bronchoalveolar lavage samples in immunosuppressed patients with suspected pneumonia: Analysis of a protocol. Respir Med. 101:2160–2167. 2007. View Article : Google Scholar : PubMed/NCBI
22	Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C and Marr KA: Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. Journal of clinical microbiology. 42:5517–5522. 2004. View Article : Google Scholar : PubMed/NCBI
23	Charles PE, Castro C, Ruiz-Santana S, León C, Saavedra P and Martín E: Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive care medicine. 35:2146–2150. 2009. View Article : Google Scholar : PubMed/NCBI
24	Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, Kopitar AN, Gmeiner-Stopar T and Derganc M: Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med. 35:1950–1958. 2009. View Article : Google Scholar : PubMed/NCBI
25	Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M and Müller B: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet. 363:600–607. 2004. View Article : Google Scholar : PubMed/NCBI
26	Bonatti H, Stelzmueller I, Berger N, Lechner M, Grif K, Geltner C, Margreiter R and Lass-Flörl C: Infections caused by Candida krusei in five transplant and two surgical patients. Surg Infect. 10:265–271. 2009. View Article : Google Scholar
27	Speletas M, Vyzantiadis T-A, Kalala F, Plastiras D, Kokoviadou K, Antoniadis A and Korantzis I: Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment. Med Mycol. 46:259–263. 2008. View Article : Google Scholar : PubMed/NCBI
28	Cascio A, Barone M, Micali V, Iaria C, Delfino D, David A, Monaco M and Monaco F: On a fatal case of Candida krusei pleural empyema in a pregnant woman with spontaneous esophagus perforation. Mycopathologia. 169:451–455. 2010. View Article : Google Scholar : PubMed/NCBI
29	Kofteridis DP, Mantadakis E, Karatzanis AD, Bourolias CA, Papazoglou G, Velegrakis GA and Samonis G: Non-Candida albicans Candida mediastinitis of odontogenic origin in a diabetic patient. Med Mycol. 46:345–348. 2008. View Article : Google Scholar : PubMed/NCBI